Sorrento Therapeutics, Inc. Financial Ratios — SRNE Stock

Profitability (USD)

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-235.34	-53.03	-39.14	-63.11	-85.37	-44.1	-29.61	-18.89	-16.35	2.19	-38.56	-49.43	-54.59	-69.61	-98.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	99.13	46.59	57.52	90.05	97.4	66.69	61.07	75.14	75.37	46.77
EBITDA Margin (%)	- -	- -	-262.06	-582.64	-780.65	-3,128.7	-819.58	-1,037.52	-699.37	38.57	-566.14	-586	-476.46	-672.13	-581.26
Operating Margin (%)	- -	- -	-265.49	-612.72	-830.82	-3,409.13	-902.82	-1,089.15	-734.76	33.87	-610.94	-620.97	-503.99	-695.68	-602.33
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	77.48	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-611.6	-829.62	-4,763.26	-950.56	-211.74	-800.64	10.09	-1,008.73	-1,143.98	-776.72	-874.28	-893.95
Profit Margin (%)	- -	- -	-264.94	-611.6	-829.62	-4,763.26	-906.07	-998.06	-747.34	6.01	-960.41	-929.21	-746.41	-809.63	-911.6
Net Income to Common Margin (%)	- -	- -	-264.94	-611.6	-829.62	-4,763.26	-906.07	-998.06	-747.34	6.01	-960.41	-929.21	-746.41	-809.63	-911.6
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Debt	- -	- -	- -	- -	- -	5	12	9	47	5	233	291	169	238	135
ST Debt	- -	- -	- -	- -	- -	- -	3	5	- -	- -	10	40	27	44	30
LT Debt	- -	- -	- -	- -	- -	4	9	4	47	5	223	251	143	194	104
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.33	-0.39	-0.19	-0.83	0.09	-1.94	-1.58	-0.89	-0.67	-0.37
Net Debt/EBITDA	- -	3.61	2.95	1.12	1.12	1.87	1.91	0.63	0.62	-0.26	-0.62	-1.16	-0.31	-0.3	-0.03
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.31	-0.35	-0.18	-0.79	0.1	-1.8	-1.49	-0.84	-0.65	-0.36
Net Debt/EBIT	- -	3.59	2.91	1.07	1.05	1.71	1.73	0.6	0.59	-0.3	-0.58	-1.09	-0.29	-0.29	-0.03
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-56.89	-19.24	-28.83	-35.41	11.76	-2.08	-5.26	-9.45	-34.78	-42.6
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-60.57	-19.61	-31.07	-39.67	9.56	-2.28	-5.58	-11.32	-35.65	-44.19
EBIT to Interest Expense	- -	- -	- -	- -	- -	-61.98	-21.2	-30.26	-37.2	10.33	-2.25	-5.57	-10	-36	-44.15
Interest Expense	- -	- -	- -	- -	- -	- -	2	2	2	5	58	35	20	10	9
Common Equity/Total Assets	- -	-29.2	-49.99	-133.05	-161.45	-35.49	-47.7	-32.99	-43.39	-38.25	-58.92	-118.32	-178.84	-199.56	-414.39
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	6.63	8.12	3.12	54.46	2.52	107.54	766.88	101.3	248.38	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-15.79	-15.95	-4.06	-39.1	-3.41	-163.56	-60.55	-17.53	-16.88	-5.71
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.79	6.24	1.28	11.73	1.21	35.75	45.05	26.61	27.93	22.07
Total Debt/Equity (%)	- -	- -	- -	- -	- -	7.19	11.17	6.55	54.7	2.52	112.43	887.72	120.37	304.08	-620.72
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-17.13	-21.94	-8.52	-39.28	-3.41	-171	-70.09	-20.83	-20.67	-7.36
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	5.19	8.58	2.69	11.78	1.21	37.38	52.15	31.61	34.19	28.45
Net Debt to Equity	- -	-107.16	-103.81	-82.35	-82.15	-40.21	-54.97	-21.15	-40.56	-7.37	35.93	649.74	41.93	135.6	-54.37
Net Debt/Capital (%)	- -	76.77	64.99	36.32	31.74	44.98	46.95	20.23	17.29	8.78	-25.26	-48.66	-6.78	-8.93	-0.64
EBITDA	- -	-1	-2	-3	-5	-14	-31	-48	-57	59	-120	-184	-191	-356	-365
EBITDA-CapEx	- -	-1	-2	-4	-5	-15	-32	-51	-64	48	-131	-196	-228	-364	-379
Operating Income (Loss)	- -	-1	-2	-3	-5	-16	-35	-50	-60	51	-129	-195	-202	-368	-379

Liquidity (USD)

API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Cash Ratio	- -	9.71	8.74	9.65	8.72	5.78	7.52	4.42	1.1	0.26	2.58	0.2	0.59	0.91	0.15
Current Ratio	- -	9.79	9.2	9.9	8.99	5.95	7.73	4.57	1.18	0.38	2.91	0.59	0.89	1.24	0.29
Quick Ratio	- -	9.71	9.15	9.82	8.85	5.85	7.6	4.5	1.14	0.31	2.65	0.32	0.75	1.04	0.23
CFO/Avg Current Liab	- -	-3.12	-3.23	-5.7	-8.05	-5.44	-3.83	-2.08	-1.33	-1.28	-1.59	-1.96	-1.51	-2.39	-1.26
Common Equity/Total Assets	- -	-29.2	-49.99	-133.05	-161.45	-35.49	-47.7	-32.99	-43.39	-38.25	-58.92	-118.32	-178.84	-199.56	-414.39
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	6.63	8.12	3.12	54.46	2.52	107.54	766.88	101.3	248.38	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-15.79	-15.95	-4.06	-39.1	-3.41	-163.56	-60.55	-17.53	-16.88	-5.71
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.79	6.24	1.28	11.73	1.21	35.75	45.05	26.61	27.93	22.07
Total Debt/Equity (%)	- -	- -	- -	- -	- -	7.19	11.17	6.55	54.7	2.52	112.43	887.72	120.37	304.08	-620.72
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-17.13	-21.94	-8.52	-39.28	-3.41	-171	-70.09	-20.83	-20.67	-7.36
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	5.19	8.58	2.69	11.78	1.21	37.38	52.15	31.61	34.19	28.45
CFO/Total Liabilities	- -	-208.16	-256.11	-763.45	-649.98	-63.98	-87.62	-20.77	-22.51	-44.08	-26.83	-32.96	-40.38	-45.7	-59.42
CFO/CapEx	- -	-16.14	-33.6	-2.61	-6.93	-17.71	-48.67	-11.35	-10.34	-9.04	-9.98	-15.12	-4.25	-31.77	-21.52
Altman's Z-Score	- -	-0.26	-0.59	-3.26	-3.71	-1.81	-1.08	-0.58	-1.41	0.1	-1.5	-3.49	-4.7	-8.6	-16.45

Working Capital (USD)

API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Accounts Receivable Turnover	- -	- -	- -	17.28	8.28	1.94	6.79	5.61	6.27	77.74	7.01	3.44	2.67	3.09	2.91
Days Sales Outstanding	- -	- -	- -	21.12	44.06	187.96	53.72	65.01	58.18	4.7	52.05	106.18	136.74	118.05	125.42
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.87	3.91	3.83	2.62	3.7
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	74.91	93.36	95.34	139.17	98.65
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	1.07	1.3	0.17	0.43	0.84	0.61	0.32	0.74	0.94
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	118,284.32	340.26	280.3	2,165.02	841.63	434.86	595.55	1,135.84	492.69	387.14
Cash Conversion Cycle	- -	- -	- -	- -	- -	-118,096.36	-286.53	-215.29	-2,106.84	-836.93	-307.9	-396.01	-903.76	-235.47	-163.07
Inventory to Cash Days	- -	- -	- -	- -	- -	187.96	53.72	65.01	58.18	4.7	-22.87	12.82	41.4	-21.12	26.77
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	3	2	8	10
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	7
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	5	3
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	3	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Market Capitalization	- -	- -	- -	- -	- -	1	3	3	2	3	3	4	16	14	4
- Cash & Cash Equivalents	- -	3	5	3	5	32	72	39	82	20	159	23	56	37	24
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	-4	6	7	-2	-46	-24	-1	-3
+ Total Debt	- -	- -	- -	- -	- -	5	12	9	47	5	233	291	169	238	135
Enterprise Value	- -	-3	-5	-3	-5	-26	-57	-128	-27	-6	75	227	104	124	85
Total Capital	- -	-1	-3	-6	-11	-28	-55	-108	-120	-153	-136	-415	-813	-1,150	-1,828
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-17.13	-21.94	-8.52	-39.28	-3.41	-171	-70.09	-20.83	-20.67	-7.36
Total Debt / EV	- -	- -	- -	- -	- -	-0.19	-0.21	-0.07	-1.74	-0.87	3.12	1.28	1.63	1.92	1.58
EV/Sales	- -	- -	- -	- -	- -	206.54	54.61	41.41	26.62	1.69	3.53	7.22	2.61	2.34	1.36
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.38	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.98	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	1	3	3	2	3	3	5	16	14	4
Diluted Enterprise Value	- -	-3	-5	-3	-5	-26	-57	-31	-26	-6	75	227	104	214	112
EV per Share	- -	- -	- -	- -	- -	6.31	7.83	5.15	4.31	3.68	0.7	1.71	0.45	0.42	0.2
TTM Sales	- -	- -	1	1	1	- -	4	5	8	152	21	31	40	53	63
TTM EBITDA	- -	-1	-2	-3	-5	-14	-31	-48	-57	59	-120	-184	-191	-356	-365
TTM Operating Income	- -	-1	-2	-3	-5	-16	-35	-50	-60	51	-129	-195	-202	-368	-379
TTM Cash Flow to Firm	- -	- -	- -	-3	-4	-16	-27	-34	-69	-82	-56	-138	-140	-272	-285
TTM Free Cash Flow to Firm	- -	- -	- -	-2	-3	-15	-27	-31	-62	-72	-45	-127	-102	-263	-272

Multiples (USD)

API ChatGPT

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	12/31/2008	12/31/2009	12/31/2010	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Price/Free Cash Flow	- -	- -	- -	- -	- -	-0.08	-0.1	-0.08	-0.04	-0.03	-0.03	-0.03	-0.13	-0.05	-0.01
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.98	- -	- -	- -	- -	- -
Enterprise Value	- -	-3	-5	-3	-5	-26	-57	-128	-27	-6	75	227	104	124	85
Low Price	- -	- -	- -	- -	- -	0.08	0.03	0.07	0.04	0.02	0.02	0.01	0.02	0.05	0.01
EV/Sales	- -	- -	- -	- -	- -	206.54	54.61	41.41	26.62	1.69	3.53	7.22	2.61	2.34	1.36
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.38	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	-0.06	-0.06	-0.1	-0.05	0.22	-0.03	-0.01	-0.05	-0.06	-0.02
Price/Earnings High	- -	- -	- -	- -	- -	-0.07	-0.13	-0.22	-0.07	0.46	-0.06	-0.03	-0.15	-0.12	-0.04
Price/Earnings Low	- -	- -	- -	- -	- -	-0.05	-0.02	-0.06	-0.04	0.11	-0.01	-0.01	-0.01	-0.03	-0.01
Price/Book Value	- -	- -	- -	- -	- -	-0.04	-0.04	-0.03	-0.01	-0.02	-0.01	-0.01	-0.02	-0.01	- -
Price/Book Value Average	- -	- -	- -	- -	- -	-0.04	-0.03	-0.04	-0.02	-0.01	-0.02	-0.01	-0.01	-0.02	- -
Price/Book Value High	- -	- -	- -	- -	- -	-0.05	-0.06	-0.09	-0.02	-0.03	-0.03	-0.01	-0.05	-0.04	-0.01
Price/Book Value Low	- -	- -	- -	- -	- -	-0.04	-0.01	-0.02	-0.01	-0.01	-0.01	- -	- -	-0.01	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	0.13	0.03	0.03	-0.12	0.03	0.02	-0.07	0.67	-0.05	-0.02
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	0.14	0.02	0.04	-0.16	0.02	0.06	-0.05	0.59	-0.09	-0.04
Price/Tangible Book Value High	- -	- -	- -	- -	- -	0.16	0.05	0.08	-0.22	0.04	0.11	-0.13	1.9	-0.2	-0.09
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	0.13	0.01	0.02	-0.11	0.01	0.02	-0.03	0.15	-0.05	-0.01
Price/Sales	- -	- -	- -	- -	- -	2.65	0.7	0.7	0.3	0.02	0.12	0.14	0.39	0.26	0.06
Price/Sales Average	- -	- -	- -	- -	- -	2.88	0.5	0.98	0.39	0.01	0.28	0.12	0.35	0.46	0.14
Price/Sales High	- -	- -	- -	- -	- -	3.37	1.14	2.16	0.53	0.03	0.54	0.27	1.12	0.96	0.33
Price/Sales Low	- -	- -	- -	- -	- -	2.57	0.22	0.58	0.26	0.01	0.1	0.06	0.09	0.26	0.05
Price/Cash Flow	- -	- -	- -	- -	- -	-0.07	-0.09	-0.08	-0.03	-0.03	-0.02	-0.03	-0.1	-0.05	-0.01
Price/Cash Flow Average	- -	- -	- -	- -	- -	-0.08	-0.07	-0.11	-0.04	-0.02	-0.05	-0.02	-0.09	-0.09	-0.03
Price/Cash Flow High	- -	- -	- -	- -	- -	-0.09	-0.15	-0.24	-0.06	-0.04	-0.1	-0.05	-0.28	-0.18	-0.07
Price/Cash Flow Low	- -	- -	- -	- -	- -	-0.07	-0.03	-0.06	-0.03	-0.01	-0.02	-0.01	-0.02	-0.05	-0.01
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	-0.09	-0.07	-0.12	-0.05	-0.02	-0.06	-0.02	-0.11	-0.09	-0.03
Price/Free Cash Flow High	- -	- -	- -	- -	- -	-0.1	-0.16	-0.26	-0.07	-0.05	-0.11	-0.06	-0.37	-0.19	-0.07
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	-0.08	-0.03	-0.07	-0.03	-0.01	-0.02	-0.01	-0.03	-0.05	-0.01
EV/Sales Average	- -	- -	- -	- -	- -	229.42	34.7	90.69	35.05	1.25	3.71	7.19	2.56	4.25	1.86
EV/Sales High	- -	- -	- -	- -	- -	278.5	98.77	208.09	49.12	2.74	3.96	7.35	3.33	4.75	2.05
EV/Sales Low	- -	- -	- -	- -	- -	198.69	6	50.32	22.74	0.64	3.52	7.14	2.3	4.05	1.76
EV/EBITDA Average	- -	3.61	2.95	1.12	1.12	1.77	1.84	0.62	0.45	-0.11	-0.66	-1.23	-0.54	-0.63	-0.32
EV/EBITDA High	- -	3.61	2.95	1.12	1.12	1.76	1.77	0.51	0.43	-0.07	-0.7	-1.25	-0.7	-0.71	-0.35
EV/EBITDA Low	- -	3.61	2.95	1.12	1.12	1.78	1.88	0.66	0.46	-0.12	-0.62	-1.22	-0.48	-0.6	-0.3
EV/EBIT Average	- -	3.59	2.91	1.07	1.05	1.63	1.67	0.59	0.43	-0.12	-0.61	-1.16	-0.51	-0.61	-0.31
EV/EBIT High	- -	3.59	2.91	1.07	1.05	1.61	1.6	0.48	0.41	-0.08	-0.65	-1.18	-0.66	-0.68	-0.34
EV/EBIT Low	- -	3.59	2.91	1.07	1.05	1.64	1.71	0.63	0.44	-0.14	-0.58	-1.15	-0.46	-0.58	-0.29
Last Price	- -	- -	- -	- -	- -	0.08	0.1	0.09	0.05	0.04	0.02	0.03	0.07	0.05	0.01
High Price	- -	- -	- -	- -	- -	0.1	0.16	0.27	0.09	0.06	0.11	0.06	0.19	0.17	0.05
Enterprise Value Average	- -	-3	-5	-3	-5	-26	-58	-30	-25	-6	79	226	102	225	117
Enterprise Value High	- -	-3	-5	-3	-5	-25	-55	-24	-24	-4	84	231	133	251	129
Enterprise Value Low	- -	-3	-5	-3	-5	-26	-59	-31	-26	-7	75	224	92	214	111

Shares Outstanding	- -	9	10	10	12	23	36	38	51	83	122	168	275	315	515
Diluted Weighted Avg Shares	4	6	9	10	11	15	27	37	50	70	106	141	230	295	419
Basic Weighted Avg Shares	4	6	9	10	11	15	27	37	50	70	106	133	230	295	419
Revenue per Share	- -	- -	0.08	0.05	0.05	0.03	0.14	0.12	0.16	2.18	0.2	0.24	0.17	0.18	0.15
EBITDA per Share	-0.01	-0.16	-0.2	-0.31	-0.4	-0.96	-1.18	-1.29	-1.13	0.84	-1.13	-1.39	-0.83	-1.21	-0.87
Operating Income per Share	-0.01	-0.16	-0.21	-0.33	-0.43	-1.04	-1.29	-1.35	-1.19	0.74	-1.22	-1.47	-0.88	-1.25	-0.9
Basic EPS, GAAP	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.24	-1.21	0.13	-1.92	-2.2	-1.3	-1.45	-1.37
Basic EPS from Cont Ops	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.36	-1.27	0.16	-2	-2.73	-1.37	-1.46	-1.38
Diluted EPS, GAAP	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.24	-1.21	0.13	-1.92	-2.08	-1.3	-1.45	-1.37
Diluted EPS from Cont Ops	-0.01	-0.15	-0.2	-0.33	-0.42	-1.46	-1.3	-1.36	-1.27	0.16	-2	-2.58	-1.37	-1.46	-1.38
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.12	-0.18	-0.28	-0.33	-1.1	-1.08	-1.14	-1.41	-1.42	-1.05	-1.3	-0.69	-0.96	-0.7
Free Cash Flow per Basic Share	- -	-0.13	-0.18	-0.38	-0.38	-1.16	-1.1	-1.24	-1.54	-1.58	-1.16	-1.39	-0.86	-0.99	-0.73
Cash & Equivalents per Share	- -	0.56	0.6	0.35	0.45	2.1	2.7	3.7	1.66	0.3	1.5	0.17	0.25	0.43	0.12
Book Value per Share	-0.03	-0.17	-0.32	-0.61	-0.96	-2.18	-2.53	-3.07	-3.46	-2.37	-3.46	-4.97	-4.17	-4.7	-4.67
Tangible Book Value per Share	-0.03	0.53	0.58	0.42	0.54	0.63	3.01	3.15	-0.39	1.4	0.97	-0.52	0.1	-0.89	-0.57

Sorrento Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)